Evidence map›Paper›PMID 23142963›Full record

ArticleBioinformatics (Oxford, England)2013

iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data.

Wenting Wang, Veerabhadran Baladandayuthapani, Jeffrey S Morris, Bradley M Broom, Ganiraju Manyam, Kim-Anh Do

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 155 citations in OpenAlex.

  1. Review
  2. Article
  3. Integrative Analysis of Multimodal Omics Data.Annual review of statistics and its application · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Multi-omics Integrative Analysis for Incomplete Data Using WeightedJournal of agricultural, biological, and environmental statistics · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. High-Dimensional Survival Analysis: Methods and Applications.Annual review of statistics and its application · 2023
    Article
  19. Review
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wenting WangDepartment of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
Veerabhadran Baladandayuthapani
Jeffrey S Morris
Bradley M Broom
Ganiraju Manyam
Kim-Anh Do
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain TumorsP50CA127001 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Juan Fueyo · 2008 to 2026
$41.2M
Targeting Tumor Microenvironment-Induced Therapy Resistance in Prostate Cancer Bone MetastasisP50CA140388 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOGOTHETIS, CHRISTOPHER J., THOMPSON, TIMOTHY CHARLES · 2009 to 2022
$23.4M
UTMDACC SPORE in Breast CancerP50CA116199 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BERRY, DONALD A · 2005 to 2009
$11.9M
Adaptive Methodology for Functional Biomedical DataR01CA107304 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MORRIS, JEFFREY S · 2004 to 2011
$1.7M
Integrative methods for high-dimensional genomics dataR01CA160736 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BALADANDAYUTHAPANI, VEERABHADRAN · 2011 to 2014
$1.4M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA116199NCI NIH HHS P50 CA127001NCI NIH HHS P50 CA127001 03NCI NIH HHS P50 CA140388NCI NIH HHS P50 CA14038802NCI NIH HHS R01 CA107304NCI NIH HHS R01 CA160736
6 · The paper itself

Abstract

motivationAnalyzing data from multi-platform genomics experiments combined with patients' clinical outcomes helps us understand the complex biological processes that characterize a disease, as well as how these processes relate to the development of the disease. Current data integration approaches are limited in that they do not consider the fundamental biological relationships that exist among the data obtained from different platforms. Statistical Model: We propose an integrative Bayesian analysis of genomics data (iBAG) framework for identifying important genes/biomarkers that are associated with clinical outcome. This framework uses hierarchical modeling to combine the data obtained from multiple platforms into one model.

resultsWe assess the performance of our methods using several synthetic and real examples. Simulations show our integrative methods to have higher power to detect disease-related genes than non-integrative methods. Using the Cancer Genome Atlas glioblastoma dataset, we apply the iBAG model to integrate gene expression and methylation data to study their associations with patient survival. Our proposed method discovers multiple methylation-regulated genes that are related to patient survival, most of which have important biological functions in other diseases but have not been previously studied in glioblastoma. AVAILABILITY: http://odin.mdacc.tmc.edu/∼vbaladan/. CONTACT: veera@mdanderson.org SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Models, StatisticalBayes TheoremBrain NeoplasmsDNA MethylationGene Expression ProfilingGenomicsGlioblastomaHumans

Identifiers

PMID23142963
PMCPMC3546799
OpenAlexW2171304795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.